Participant recruitment completed for the phase II clinical trial with Niccine®, Independent Pharmaceutica’s nicotine vaccine”.

Swedish vaccine against smoking enters clinical trial phase II

Over 4 MUSD invested in a new anti smoking vaccine clinical trial